Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?

NCT01964404 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT01964404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2014
Completion date
September 18, 2021
Enrollment
263 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use disorder, dual diagnosis, psychotic disorder, schizophrenia